Controlling the fate of cells

A protein found in cells has been shown to play a pivotal role in determining whether a cell lives or dies.

This has important implications for many human diseases as it may contribute to the development of new therapies.

Dr Jon Lane and colleagues in the University of Bristol's Department of Biochemistry have shown for the first time that the protein Atg4D can exist in two forms. In its original form, Atg4D promotes cell survival through 'autophagy', a survival mechanism used by cells to overcome various environmental stresses, including starvation, and to control normal cellular processes such as growth and development

In a modified form, Atg4D can attach to the power units of the cell - the mitochondria - to stimulate cell death via 'apoptosis'. Their research is reported in the July issue of the Journal of Cell Science.

The biological processes of autophagy and apoptosis are closely linked, and as such both play an essential role in cancer and neurodegenerative diseases such as Parkinson's and Alzheimer's.

Dr Lane explains: "Understanding how this protein is regulated may provide new approaches to control the fate of cells in important human diseases".

In cancer, cells fail to undergo apoptosis, allowing them to grow uncontrollably and develop into tumours. In contrast, the activation of apoptosis in neurodegenerative diseases is detrimental, contributing to the progression of the disease. The role of autophagy in disease is less clear, however, its activation may prevent or halt the development of some neurodegenerative diseases and cancers. Clearly, the finding that Atg4D has a dual role in controlling both autophagy and apoptosis has important implications for many human diseases. It may ultimately contribute to the development of new therapies.

The paper: Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis, by Virginie M. S. Betin and Jon D. Lane. Journal of Cell Science 122 (14), 2554-2566.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer